Search Results - "Rodler S"

Polyethylene glycol-coated collagen patch (hemopatch^®) in open partial nephrectomy.

Authors: Staehler, Michael Rodler, S. Schott, M. et al.

Source: World Journal of Urology. Jan2022, Vol. 40 Issue 1, p127-132. 6p.

A0193 - Exploring the efficiency of generative artificial intelligence in rapidly and accurately producing patient information for urological malignancy treatments aligned with the latest EAU guidelines.

Authors: Rodler, S. Ramacciotti, L.S. Checcucci, E. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS947-S948. 2p.

18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results.

Authors: Mittlmeier, L. M. Unterrainer, M. Rodler, S. et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jun2021, Vol. 48 Issue 6, p2031-2037. 7p. 2 Color Photographs, 2 Charts.

A1274 - Radiomics in the differentiation between upper tract urothelial carcinoma and renal cell carcinoma – can we overcome the performance of conventional diagnostics by machine learning?

Authors: Rodler, S. Rzany, M. Buchner, A. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS1852-S1852. 1p.

A0543 - Expression of Nectin-4 in variant histologies of bladder cancer – implications for future trials?

Authors: Rodler, S. Schlenker, B. Casuscelli, J. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS775-S775. 1p.

A0376 - Robotic radiosurgery for the treatment of lung metastases of renal cell carcinoma.

Authors: Rodler, S. Schott, M. Casuscelli, J. et al.

Source: European Urology. 2022 Supplement 1, Vol. 81, pS585-S585. 1p.

139P - Patient's perspective on digital biomarkers in advanced urologic malignancies.

Authors: Rodler, S. Buchner, A. Schott, M. et al.

Source: Annals of Oncology. 2019 Supplement 6, Vol. 30, pv43-v44. 2p.

119 Interleukin-22 (IL-22), a T-cell secreted cytokine, contributes to renal cell carcinoma (RCC) progression and is associated with poor outcome in RCC patients.

Authors: Rodler, S. Shangqing, S. Weidenbusch, M. et al.

Source: European Urology Supplements. Mar2016, Vol. 15 Issue 3, pe119-e119. 1p.

A0175 - Impact of total laser energy on functional outcome following holmium laser enucleation of the prostate.

Authors: Westhofen, T. Eismann, L. Rodler, S. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS916-S917. 2p.

Exercise capacity and performance diagnostics of heart transplant recipients. (Abstract)

Authors: Rohrer, A. Pokan, R. Smekal, G. et al.

Source: 01/01/2002.

A1054 - MRI/TRUS fusion-guided transperineal versus transrectal prostate biopsy: A large, multiracial and ethnically diverse cohort.

Authors: Storino Ramacciotti, L. Kaneko, M. Rodler, S. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS2173-S2173. 1p.

A0293 - A green biopsy expedited prostate cancer diagnostic pathway: Carbon footprint assessment and clinical outcomes.

Authors: Storino Ramacciotti, L. Kaneko, M. Rodler, S. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS1088-S1088. 1p.

A1057 - Transperineal prostate biopsy: An international Delphi consensus for best clinical practices.

Authors: Storino Ramacciotti, L. Cacciamani, G.E. Kaneko, M. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS2177-S2179. 3p.

1764P The vanishing clinical value of PD-L1 status as predictive biomarker in first-line treatment of urothelial carcinoma of the bladder.

Authors: Tamalunas, A. Götz, M. Rodler, S. et al.

Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1345-S1345. 1p.

PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma.

Authors: Mittlmeier, L. M. Unterrainer, M. Todica, A. et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Aug2020, Vol. 47 Issue 9, p2216-2217. 2p. 1 Color Photograph.

A0192 - Evaluating the effectiveness of ChatGPT in disseminating accurate and readable prostate cancer information.

Authors: Eppler, M. Hershenhouse, J.S. Mokhtar, D. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS945-S946. 2p.

P173 - Perioperative outcomes and evolution of penile prosthesis implantation in Germany: Results from the GRAND study.

Authors: Pyrgidis, N. Schulz, G.B. Chaloupka, M. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS243-S244. 2p.

A1234 - Adverse pathology of prostate cancer after radical prostatectomy. Summary after 7 years and 1500 patients since introduction of mpMRI-guided biopsy in a real world setting.

Authors: Ebner, B. Apfelbeck, M. Pyrgidis, N. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS1791-S1792. 2p.

473: CD4⁺ CD25⁺ Regulatory T-cell Levels Are Associated with Cardiac Allograft Vasculopathy

Authors: Aharinejad, S. Gmeiner, M. Rodler, S. et al.

Source: Journal of Heart & Lung Transplantation. Feb2010 Supplement, Vol. 29 Issue 2, pS155-S155. 1p.

A1169 - Intratumoral heterogeneity of molecular subtypes in muscle-invasive bladder cancer – An extensive multi-regional immunohistochemical analysis.

Authors: Schallenberg, S. Dragomir, M. Anders, P. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS1688-S1688. 1p.